Q3 2025 · 13F-HR
SB INVESTMENT ADVISERS (UK) LTDholdings as filed
Filed 2025-11-14 · accession 0001493152-25-023521
$13.25B
Reported value
10
Positions
2025-09-30
Period end
The Brief · SB INVESTMENT ADVISERS (UK) LTD · Q3 2025
AI · grounded in 13F
SB INVESTMENT ADVISERS (UK) LTD established a new position in CPNG valued at $9.32B. The fund also initiated a new stake in GRAB HOLDINGS LIMITED worth $2.42B. Additional new positions include ROIVANT SCIENCES LTD at $610M and COMP at $359M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 22266T109 | CPNG | COUPANG INC | $9.32B | 70.3% | 289,542,259 | Common | SOLE |
| G4124C109 | GRAB | GRAB HOLDINGS LIMITED | $2.42B | 18.2% | 401,796,672 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $610.0M | 4.60% | 40,315,127 | Common | SOLE |
| 20464U100 | COMP | COMPASS INC | $359.4M | 2.71% | 44,761,137 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $145.7M | 1.10% | 27,904,963 | Common | SOLE |
| 35969L108 | YMM | FULL TRUCK ALLIANCE CO LTD | $131.3M | 0.99% | 10,125,112 | Common | SOLE |
| 051774107 | AUR | AURORA INNOVATION INC | $106.8M | 0.81% | 19,811,760 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $95.3M | 0.72% | 16,684,041 | Common | SOLE |
| 29280W109 | NRGV | ENERGY VAULT HOLDINGS INC | $55.1M | 0.42% | 18,535,631 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $8.9M | 0.07% | 610,729 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.